Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 5/2012

01-10-2012 | Short Research Report

Attitudes of Portuguese health professionals toward adverse drug reaction reporting

Authors: Sílvia Isabel dos Santos Pernas, Maria Teresa Herdeiro, Elena Lopez-Gonzalez, Odete A. B. da Cruz e Silva, Adolfo Figueiras

Published in: International Journal of Clinical Pharmacy | Issue 5/2012

Login to get access

Abstract

Background Adverse drug reactions are a major public health problem. Underreporting is an important limitation of all reporting systems, partially due to attitudes of health professionals. Objective This study sought: (1) to evaluate the reproducibility of a questionnaire on attitudes to and knowledge of adverse drug reaction (ADR) reporting among physicians, nurses and pharmacists: and (2) to compare the attitudes and knowledge of these three groups of health professionals. Methods This study targeted a sample of physicians (n = 30), nurses (n = 30) and pharmacists (n = 20) in the central region of Portugal. A structured questionnaire was administered to each health professional twice, at an interval of 2–4 weeks. Most attitudes were based on Inman’s ‘seven deadly sins’ and measured using a continuous visual analog scale (VAS), with answers scored from 0 (total disagreement) to 10 (total agreement). Questionnaire reproducibility was determined using the intraclass correlation coefficient (ICC). Results The response rate was 100 %. Attitudes that registered the highest ICCs were Complacency (the belief that really serious ADRs are well documented by the time a drug is marketed) (physicians, ICC 0.84; nurses, ICC 0.70; pharmacists, ICC 0.99), and Diffidence (the belief that one would only report an ADR if one were sure that it was related to the use of a particular drug) (physicians, ICC 0.73; nurses, ICC 0.65; pharmacists, ICC 0.98). In most cases, there were no differences among the three groups of professionals in terms of attitudes and knowledge. Conclusions The Horizontal continuous VAS is reliable to detect the knowledge and attitudes about ADRs.
Literature
1.
go back to reference Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. Jr Am Med Assoc. 1998;279:1200–5.CrossRef Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. Jr Am Med Assoc. 1998;279:1200–5.CrossRef
2.
go back to reference Leendertse AJ, Visser D, Egberts A, van den Bemt PMLA. The relationship between study characteristics and the prevalence of medication-related hospitalizations: a literature review and novel analysis. Drug Saf. 2010;33(3):233–44.PubMedCrossRef Leendertse AJ, Visser D, Egberts A, van den Bemt PMLA. The relationship between study characteristics and the prevalence of medication-related hospitalizations: a literature review and novel analysis. Drug Saf. 2010;33(3):233–44.PubMedCrossRef
3.
go back to reference WHO: Importance of Pharmacovigilance. Geneve: World Health Organization (2002). ISBN: 924-1590157. WHO: Importance of Pharmacovigilance. Geneve: World Health Organization (2002). ISBN: 924-1590157.
4.
go back to reference Erill S. Avances en las técnicas de detección de reacciones adverses a los medicamentos. In: Laporte J, Salva JÁ, editors. Avances en terapéutica, vol. 5. Barcelona: Editorial Salvat; 1973, p. 124–48. ISBN: 978-84-97991-10-0. Erill S. Avances en las técnicas de detección de reacciones adverses a los medicamentos. In: Laporte J, Salva JÁ, editors. Avances en terapéutica, vol. 5. Barcelona: Editorial Salvat; 1973, p. 124–48. ISBN: 978-84-97991-10-0.
5.
go back to reference Smith CC, Bennett PM, Pearce HM, Harrison PI, Reynolds DJ, Aronson JK, et al. Adverse drug reaction in a hospital general medical unit meriting notification to the Committee on Safety of Medicine. Br J Clin Pharmacol. 1996;42:423–9.PubMedCrossRef Smith CC, Bennett PM, Pearce HM, Harrison PI, Reynolds DJ, Aronson JK, et al. Adverse drug reaction in a hospital general medical unit meriting notification to the Committee on Safety of Medicine. Br J Clin Pharmacol. 1996;42:423–9.PubMedCrossRef
6.
go back to reference Pirmohamed M, Breckenridge A, Kitteringham N, Park BK. Adverse drug reactions. Br Med J. 1998;316:1295–8.CrossRef Pirmohamed M, Breckenridge A, Kitteringham N, Park BK. Adverse drug reactions. Br Med J. 1998;316:1295–8.CrossRef
8.
go back to reference Inman W. Assessment of drug safety problems. In: Gent M, Honolulu SI, editors. Epidemiological issues in reported drug-induced illnesses. McMaster University Library Press: Honolulu; 1976; p. 17–24. ISBN: 0919592023. Inman W. Assessment of drug safety problems. In: Gent M, Honolulu SI, editors. Epidemiological issues in reported drug-induced illnesses. McMaster University Library Press: Honolulu; 1976; p. 17–24. ISBN: 0919592023.
9.
go back to reference Inman W, Weber JCT. The United Kingdom. In: Inman WHW, editor. Monitoring for drug safety, 2nd edn. Lancaster: MTP Press Ltd. 1986; p. 13–47. ISBN: 0852007213. Inman W, Weber JCT. The United Kingdom. In: Inman WHW, editor. Monitoring for drug safety, 2nd edn. Lancaster: MTP Press Ltd. 1986; p. 13–47. ISBN: 0852007213.
10.
go back to reference Inman W. Attitudes to adverse drug-reaction reporting. Br J Clin Pharmacol. 1996;41:433–5. Inman W. Attitudes to adverse drug-reaction reporting. Br J Clin Pharmacol. 1996;41:433–5.
11.
go back to reference Figueiras A, Tato F, Fontaiñas J, Gestal-Otero JJ. Influence of physicians’ attitudes on reporting adverse drug events: a case-control. Med Care. 1999;37(8):809–14.PubMedCrossRef Figueiras A, Tato F, Fontaiñas J, Gestal-Otero JJ. Influence of physicians’ attitudes on reporting adverse drug events: a case-control. Med Care. 1999;37(8):809–14.PubMedCrossRef
12.
go back to reference Herdeiro MT, Figueiras A, Polónia J, Gestal-Otero JJ. Physicians’ attitudes and adverse drug reaction reporting: a case-control study in Portugal. Drug Saf. 2005;28(9):825–33.PubMedCrossRef Herdeiro MT, Figueiras A, Polónia J, Gestal-Otero JJ. Physicians’ attitudes and adverse drug reaction reporting: a case-control study in Portugal. Drug Saf. 2005;28(9):825–33.PubMedCrossRef
13.
go back to reference Herdeiro MT, Figueiras A, Polónia J, Gestal-Otero JJ. Influence of pharmacists’ attitudes on adverse drug reaction reporting: a case-control study in Portugal. Drug Saf. 2006;29(4):331–40.PubMedCrossRef Herdeiro MT, Figueiras A, Polónia J, Gestal-Otero JJ. Influence of pharmacists’ attitudes on adverse drug reaction reporting: a case-control study in Portugal. Drug Saf. 2006;29(4):331–40.PubMedCrossRef
14.
go back to reference Green FC, Mottram DR, Rowe PH, Pirmohamed M. Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. Br J Clin Pharmacol. 2001;51:81–6.PubMedCrossRef Green FC, Mottram DR, Rowe PH, Pirmohamed M. Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. Br J Clin Pharmacol. 2001;51:81–6.PubMedCrossRef
15.
go back to reference Rogers AS, Israel E, Smith CR, Levine D, McBean AM, Valente C, et al. Physician knowledge, attitudes and behaviour related to reporting adverse drug events. Arch Intern Med. 1988;148:1596–600.PubMedCrossRef Rogers AS, Israel E, Smith CR, Levine D, McBean AM, Valente C, et al. Physician knowledge, attitudes and behaviour related to reporting adverse drug events. Arch Intern Med. 1988;148:1596–600.PubMedCrossRef
16.
go back to reference Scott HD, Thatcher A, Rosenbaum SE, Waters WJ, Green M. Adverse drug reaction reporting systems: the United Kingdom and the Unit States. R I Med J. 1988;71:179–84.PubMed Scott HD, Thatcher A, Rosenbaum SE, Waters WJ, Green M. Adverse drug reaction reporting systems: the United Kingdom and the Unit States. R I Med J. 1988;71:179–84.PubMed
17.
go back to reference Backstrom M, Ekman E, Mjorndal T. Adverse drug reaction reporting by nurses in Sweden. Eur J Clin Pharmacol. 2007;63:613–8.PubMedCrossRef Backstrom M, Ekman E, Mjorndal T. Adverse drug reaction reporting by nurses in Sweden. Eur J Clin Pharmacol. 2007;63:613–8.PubMedCrossRef
18.
go back to reference Nickerson CAE. A note on ‘A concordance correlation coefficient to evaluate reproducibility’. Biometrics. 1997;53(4):1503–7.CrossRef Nickerson CAE. A note on ‘A concordance correlation coefficient to evaluate reproducibility’. Biometrics. 1997;53(4):1503–7.CrossRef
19.
go back to reference Quinn C, Haber MJ, Pan Y. Use of the concordance correlation coefficient when examining agreement in dyadic research. Nurs Res. 2009;58(5):368–73.PubMedCrossRef Quinn C, Haber MJ, Pan Y. Use of the concordance correlation coefficient when examining agreement in dyadic research. Nurs Res. 2009;58(5):368–73.PubMedCrossRef
20.
go back to reference Siegel S, Castellan NP. Nonparametric statistics for behavioral sciences, 2nd edn. USA: McGraw-Hill. 1988. ISBN 978-0070573574. Siegel S, Castellan NP. Nonparametric statistics for behavioral sciences, 2nd edn. USA: McGraw-Hill. 1988. ISBN 978-0070573574.
21.
go back to reference Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of underreporting of adverse drug reactions: a systematic review. Drug Saf. 2009;32:19–31.PubMedCrossRef Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of underreporting of adverse drug reactions: a systematic review. Drug Saf. 2009;32:19–31.PubMedCrossRef
22.
go back to reference Russell VL. Some practical guidelines for effective sample size determination. Am Stat. 2001;55(3):187–93.CrossRef Russell VL. Some practical guidelines for effective sample size determination. Am Stat. 2001;55(3):187–93.CrossRef
Metadata
Title
Attitudes of Portuguese health professionals toward adverse drug reaction reporting
Authors
Sílvia Isabel dos Santos Pernas
Maria Teresa Herdeiro
Elena Lopez-Gonzalez
Odete A. B. da Cruz e Silva
Adolfo Figueiras
Publication date
01-10-2012
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 5/2012
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-012-9675-6

Other articles of this Issue 5/2012

International Journal of Clinical Pharmacy 5/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.